These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6811101)

  • 1. Release of thyrotropin releasing hormone into hypophysial portal blood is high relative to other neuropeptides and may be related to prolactin secretion.
    Fink G; Koch Y; Ben Aroya N
    Brain Res; 1982 Jul; 243(1):186-9. PubMed ID: 6811101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levels of dopamine and thyrotrophin-releasing hormone in hypophysial stalk blood during an oestrogen-stimulated surge of prolactin in the ovariectomized rat.
    de Greef WJ; Klootwijk W; Karels B; Visser TJ
    J Endocrinol; 1985 Apr; 105(1):107-12. PubMed ID: 3157761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Release of prolactin is independent of the secretion of thyrotrophin-releasing hormone into hypophysial portal blood of sheep.
    Thomas GB; Cummins JT; Yao B; Gordon K; Clarke IJ
    J Endocrinol; 1988 Apr; 117(1):115-22. PubMed ID: 3128621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is thyrotropin-releasing hormone immunoreactivity in peripheral blood an estimate for hypothalamic thyrotropin-releasing hormone release?
    de Greef WJ; Rondeel JM; Heide R; Klootwijk W; Visser TJ
    Acta Endocrinol (Copenh); 1992 Mar; 126(3):276-81. PubMed ID: 1574958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-dependent inhibition of the preovulatory surges of gonadotropins and prolactin by the antiestrogen CI-628: possible sites of action.
    De Paolo LV
    Biol Reprod; 1985 May; 32(4):745-52. PubMed ID: 3924129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of progesterone in regulating the effect of estradiol on the secretion of thyrotropin-releasing hormone and dopamine into hypophysial portal blood in ovariectomized rats.
    Huang SW; Tsai SC; Tung YF; Wang PS
    Neuroendocrinology; 1995 May; 61(5):536-41. PubMed ID: 7617131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The development of the releasing factor concept.
    Fink G
    Clin Endocrinol (Oxf); 1976; 5 Suppl():245S-260S. PubMed ID: 29735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in serum growth hormone and prolactin levels, and in hypothalamic growth hormone-releasing hormone, thyrotropin-releasing hormone and somatostatin content, after superior cervical sympathectomy in rats.
    Cardinalí DP; Esquifino AI; Arce A; Vara E; Ariznavarreta C; Tresguerres JA
    Neuroendocrinology; 1994 Jan; 59(1):42-8. PubMed ID: 7908422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The physiological role of thyrotropin-releasing hormone in the regulation of thyroid-stimulating hormone and prolactin secretion in the rat.
    Harris AR; Christianson D; Smith MS; Fang SL; Braverman LE; Vagenakis AG
    J Clin Invest; 1978 Feb; 61(2):441-8. PubMed ID: 413840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of thyroid status and paraventricular area lesions on the release of thyrotropin-releasing hormone and catecholamines into hypophysial portal blood.
    Rondeel JM; de Greef WJ; van der Schoot P; Karels B; Klootwijk W; Visser TJ
    Endocrinology; 1988 Jul; 123(1):523-7. PubMed ID: 3133200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of immunoneutralization of thyrotrophin-releasing hormone on the release of thyrotrophin and prolactin during suckling or in response to electrical stimulation of the hypothalamus in the anaesthetized rat.
    Sheward WJ; Fraser HM; Fink G
    J Endocrinol; 1985 Jul; 106(1):113-9. PubMed ID: 3926927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temporal relationships between the circadian rhythmicity in plasma levels of pituitary hormones and in hypothalamic concentrations of releasing factors.
    Szafarczyk A; Hery M; Laplante E; Ixart G; Assenmacher I; Kordon C
    Neuroendocrinology; 1980 Jun; 30(6):369-76. PubMed ID: 6247669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interrelationship between thyroxine and estradiol on the secretion of thyrotropin-releasing hormone and dopamine into hypophysial portal blood in ovariectomized-thyroidectomized rats.
    Wang PS; Huang SW; Tung YF; Pu HF; Tsai SC; Lau CP; Chien EJ; Chien CH
    Neuroendocrinology; 1994 Mar; 59(3):202-7. PubMed ID: 8159269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between luteinizing hormone releasing hormone concentration in hypophysial portal blood and luteinizing hormone release in intact, castrated, and electrochemically-stimulated rats.
    Eskay RL; Mical RS; Porter JC
    Endocrinology; 1977 Feb; 100(2):263-70. PubMed ID: 318992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Release of thyrotropin and prolactin by a thyrotropin-releasing hormone (TRH) precursor, TRH-Gly: conversion to TRH is sufficient for in vivo effects.
    Pekary AE; Stephens R; Simard M; Pang XP; Smith V; DiStefano JJ; Hershman JM
    Neuroendocrinology; 1990 Dec; 52(6):618-25. PubMed ID: 2126612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of prolactin and thyrotropin secretion in the rat by antiserum to thyrotropin-releasing hormone.
    Koch Y; Goldhaber G; Fireman I; Zor U; Shani J; Tal E
    Endocrinology; 1977 May; 100(5):1476-8. PubMed ID: 403069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for thyrotropin-releasing hormone and glucocorticoid receptor-immunoreactive neurons in various preoptic and hypothalamic nuclei of the male rat.
    Cintra A; Fuxe K; Wikström AC; Visser T; Gustafsson JA
    Brain Res; 1990 Jan; 506(1):139-44. PubMed ID: 2105819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyrotropin-releasing hormone affects the oxytocin, vasopressin and prolactin release in female rats during midlactation: relation to suckling.
    Ciosek J; Guzek JW
    J Physiol Pharmacol; 1998 Mar; 49(1):135-50. PubMed ID: 9594417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of opioid peptides and potassium on the release of vasoactive intestinal polypeptide and thyrotropin releasing hormone from perifused rat hypothalami.
    Burns G; Baker DJ; Brown BL; Dobson PR
    Life Sci; 1987 Mar; 40(10):951-7. PubMed ID: 3102870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The peak phase of the proestrous prolactin surge is blocked by either posterior pituitary lobectomy or antisera to vasoactive intestinal peptide.
    Murai I; Reichlin S; Ben-Jonathan N
    Endocrinology; 1989 Feb; 124(2):1050-5. PubMed ID: 2492217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.